A malignant hyperthermia-like reaction in a six-month-old female with a 5q chromosomal deletion
To the Editor:
We encountered a six-month-old female with 5q-syndrome, who developed progressive tachycardia, hypercarbia and hyperthermia following a general anesthetic given for repair of a cleft palate. Two weeks prior, the infant had received a sevoflurane anesthetic during a magnetic resonance imaging scan of the brain.
Immediately following this procedure, she experienced a self-limited episode of fever and tachycardia that were attributed to overzealous warming of the infant by the nursing staff. Body stiffness was not described. In accordance with our Human Research Protection Program, formal review and approval of this document were not required. General anesthesia for the cleft palate repair was induced using sevoflurane and nitrous oxide, followed by neuromuscular blockade with of rocuronium 0.8 mg·kg -1 iv. Following laryngoscopy and intubation, anesthesia was maintained with isoflurane, nitrous oxide and oxygen. During the case all physiologic parameters were within normal limits. Upon completion of the repair the trachea was extubated. Vital signs on admission to the recovery room were unremarkable: heart rate 105 beats·min -1 , respiratory rate 20 breaths·min -1 , blood pressure 96/40 mmHg, temperature 37°C.
Approximately one hour later, examination revealed a heart rate of 220 beats·min -1 , respiratory rate of 60 breaths·min -1 , blood pressure of 126/62 mmHg, and an axillary temperature of 39.9°C. Inspection of the child showed her to be in severe respiratory distress with hypertonia. A venous blood gas sample was obtained: pH 7.12 /CO 2 270 /PO 2 271 mmHg /base excess -6.0. The child was intubated and cooling measures rapidly instituted. The hypermetabolic state rapidly resolved following the administration of dantrolene sodium (3 mg·kg -1 ). The infant was admitted to the pediatric intensive care unit and subsequently received three more doses of dantrolene (1 mg·kg -1 ). Serial laboratory examinations at 12, 24 and 36 hr revealed a peak serum creatine phosphokinase (CPK) of 260 IU·L -1 with consistently normal serum electrolytes. She exhibited a full recovery, and was discharged from the hospital five days later, in good condition. This is the first report of a malignant hyperthermic reaction occurring in a patient with a chromosomal deletion of 5q. Interestingly, the infant's serum CPK level increased only modestly following the anesthetic. We attribute this to the young age of the patient, prompt treatment, and the rapid resolution of symptoms following institution of therapy. It is possible that older infants and adults exhibit more marked elevations in serum CPK due to their relative increased muscle mass. Also noteworthy, was the self-limited fever and tachycardia following her initial anesthetic. Unexplained fever and tachycardia after general anesthesia, in patients as young as six months of age should be considered possible precursors to malignant hyperthermia. regarding pudendal block with nerve stimulator guidance, and offer the following comments. This is the first randomized study demonstrating the efficacy of such blocks in providing postoperative analgesia following hemorroidectomy.
However, we are surprised by the landmarks proposed by the authors. Why did they use two injection points side by side?
We usually use this block for gynecological surgery (bartholin cyst removal and perineal surgery) and we use only one injection point at the intersection of a horizontal line running with the medial edge of the ischial tuberosity from the superior aspect of the anus.
2 In our experience, the mean depth of stimulation is 45.1 ± 11.6 mm (25-80) and the mean stimulation intensity is 0.6 ± 0.1 mA (0.5-1).
Motor responses are :
• contraction of the external anal sphincter (lower rectal response) and contraction of the vulva constrictor muscle (perineal response) in 52%; • contraction of the external anal sphincter alone in 27%; • contraction of the vulva constrictor muscle alone in 11%;
• contraction of the external anal sphincter, contraction of the vulva constrictor muscle and movement of the clitoris in 8%; • No motor response in 2%. In our opinion, the risk of the posterior injection points is an extension of the block to the sciatic nerve. This risk must be considered with a bilateral injection in ambulatory patients. 
